High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluid of patients at high risk for second primary lung cancer.

A high frequency of K-ras mutations may indicate preneoplastic changes in the bronchial epithelium as a result of genotoxic injury. With the use of sensitive detection techniques, we report a higher prevalence of K-ras mutations in bronchoalveolar lavage than has been reported previously for lung cancer. A PCR/ligase chain reaction technique was used to determine K-ras codon 12 mutations in a group of 52 bronchoalveolar lavage specimens from patients at risk of a second lung cancer. Of the specimens examined, 84% contained at least one mutation in K-ras codon 12, corroborated by an allele-specific hybridization method. These results suggest that point mutations in K-ras codon 12 are widespread in the bronchial epithelium. Based on these preliminary findings, further evaluation of this efficient sensitive assay to monitor K-ras status should be conducted in larger clinical cohorts where clinical outcomes will ultimately be available. Such a trial will define the utility of K-ras codon 12 mutation status as a marker of lung cancer.

[1]  V. Rotter,et al.  Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation , 1984, Nature.

[2]  S. Rodenhuis,et al.  The ras gene family in human non-small-cell lung cancer. , 1992, Journal of the National Cancer Institute. Monographs.

[3]  R. Hruban,et al.  Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. , 1994, Cancer research.

[4]  J. Mulshine,et al.  Detection of K-ras oncogene mutations by polymerase chain reaction-based ligase chain reaction. , 1996, Analytical Biochemistry.

[5]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[6]  M. Tockman,et al.  Prospective trial evaluating immunocytochemical‐based sputum techniques for early lung cancer detection: Assays for promotion factors in the bronchial lavage , 1993, Journal of cellular biochemistry. Supplement.

[7]  Wendy I. Wilson,et al.  Ligase chain reaction (LCR)--overview and applications. , 1994, PCR methods and applications.

[8]  R. Katakura,et al.  Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. , 1991, Oncogene.

[9]  D. Jacobson,et al.  A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia. , 1994, Oncogene.

[10]  F. Barany.  Genetic disease detection and DNA amplification using cloned thermostable ligase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Kumar,et al.  Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes. , 1989, Oncogene research.

[12]  W. Rom,et al.  Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. , 1995, Cancer research.

[13]  D. Sidransky.  Molecular screening--how long can we afford to wait? , 1994, Journal of the National Cancer Institute.

[14]  J. Bishop,et al.  Predisposition to neoplastic transformation caused by gene replacement of H-ras1. , 1993, Science.

[15]  M. Tockman,et al.  The early detection of second primary lung cancers by sputum immunostaining. LCEWDG Investigators. Lung Cancer Early Detection Group. , 1994, Chest.

[16]  Z. Ronai,et al.  High frequency of K‐ras mutations in normal appearing lung tissues and sputum of patients with lung cancer , 1995, International journal of cancer.

[17]  R. deVere White,et al.  Activated ras alleles in human carcinoma of the prostate are rare. , 1991, Cancer research.

[18]  Z. Ronai,et al.  Detection of K-ras mutation in colonic effluent samples from patients without evidence of colorectal carcinoma. , 1994, Journal of the National Cancer Institute.

[19]  M. Birrer.  Translational research and epithelial carcinogenesis: molecular diagnostic assays now--molecular screening assays soon? , 1995, Journal of the National Cancer Institute.

[20]  A. Gazdar,et al.  K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. , 1994, Cancer research.

[21]  J. Mulshine,et al.  Molecular markers in early cancer detection. New screening tools. , 1995, Chest.

[22]  R. Hruban,et al.  K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. , 1996, Cancer research.

[23]  D. Shibata,et al.  c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung. , 1994, The American journal of pathology.

[24]  M. Tockman,et al.  Peptide amidating activity in human bronchoalveolar lavage fluid. , 1996, Lung cancer.

[25]  T. Sekiya,et al.  Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. , 1990, Oncogene.

[26]  J. Dr,et al.  A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia. , 1994 .

[27]  W. Rom,et al.  Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis. , 1995, Journal of the National Cancer Institute.

[28]  P. Wingo,et al.  Cancer statistics, 1996 , 1996, CA: a cancer journal for clinicians.

[29]  M. Kimmey,et al.  Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. , 1995, Cancer research.